The link between depleted omega-6 fatty acid levels and retinopathy of prematurity
Ruth Steer |
When babies are born pre-term, the final stages of retinal development can be disrupted by the intensive oxygen therapy administered to compensate for underdeveloped lungs, leading to retinopathy of prematurity (ROP) in some cases – and potentially blindness. It’s why many researchers are on a quest to determine how best to support the ongoing retinal development and avoid disease.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
- ClinicalTrials.gov. “A fatty acids study in preventing retinopathy of prematurity: NCT02760472”. Available at: bit.ly/DonnaMega. Accessed February 15, 2018.
- CA Löfqvist et al., “Association of retinopathy of prematurity with low levels of arachidonic acid”, JAMA Ophthalmol, [Epub ahead of print], (2018). PMID: 29423508.
- Margareta Gustafsson Kubista. “New discovery offers hope of protecting premature babies from blindness”. Available at: bit.ly/ROPDiscovery. Accessed: February 15, 2018.